£13.0M
The financing round was led by Oxford Science Enterprises and will support market expansion in the UK, EU, and United States.
CD
Caristo Diagnostics
Caristo Diagnostics develops AI-assisted tools for cardiac and vascular disease diagnostics.
Oxford, UK—Founded 2018
£13.0MTotal raised
Caristo Diagnostics is a medical technology company developing advanced diagnostic tools for cardiac and vascular diseases. It provides AI-assisted imaging platforms designed to predict and prevent heart attacks.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Current assets
Members only
Cash, assets and headcount from Caristo Diagnostics's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
Oran Muduroglu
Board Chairman
Oran brings leadership experience across several medical technology and diagnostics companies, including roles as executive chairman at Median Technologies and Rapid Infection Diagnostics. He previously co-founded Coeus Health and led care delivery platforms at Verily.
LinkedInFC